ARTA
ACHN

A.R.T. Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

A.R.T. Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-173,211
Closed -$624K – 1913
2019
Q3 		$624K Buy
173,211
+46,400
+37% +$179K 0.03% 764
2019
Q2 		$340K Buy
126,811
+76,500
+152% +$226K 0.02% 903
2019
Q1 		$149K Buy
+50,311
New +$124K 0.01% 1120
2018
Q4 		– Sell
-75,296
Closed -$277K – 1841
2018
Q3 		$277K Buy
+75,296
New +$224K 0.01% 1073
2018
Q2 		– Sell
-185,913
Closed -$689K – 1929
2018
Q1 		$689K Buy
185,913
+52,800
+40% +$173K 0.03% 809
2017
Q4 		$383K Buy
133,113
+50,400
+61% +$183K 0.02% 994
2017
Q3 		$371K Sell
82,713
-47,837
-37% -$212K 0.02% 938
2017
Q2 		$599K Buy
+130,550
New +$525K 0.03% 727
2017
Q1 		– Sell
-18,300
Closed -$75K – 1847
2016
Q4 		$75K Sell
18,300
-36,100
-66% -$192K ﹤0.01% 1186
2016
Q3 		$440K Buy
+54,400
New +$463K 0.14% 229
2016
Q2 		– Sell
-46,679
Closed -$360K – 1769
2016
Q1 		$360K Buy
+46,679
New +$342K 0.02% 981
2015
Q4 		– Sell
-394,723
Closed -$2.73M – 1840
2015
Q3 		$2.73M Buy
394,723
+155,844
+65% +$1.27M 0.1% 279
2015
Q2 		$2.12M Buy
238,879
+78,201
+49% +$740K 0.07% 422
2015
Q1 		$1.58M Sell
160,678
-65,293
-29% -$815K 0.05% 475
2014
Q4 		$2.77M Sell
225,971
-463,272
-67% -$5.66M 0.1% 278
2014
Q3 		$6.88M Buy
+689,243
New +$6.4M 0.32% 63
2013
Q4 		– Sell
-264,070
Closed -$797K – 1632
2013
Q3 		$797K Sell
264,070
-32,304
-11% -$221K 0.04% 598
2013
Q2 		$2.42M Buy
+296,374
New +$2.26M 0.08% 347

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

A.R.T. Advisors's ACHN Position: Q4 2019 in Review

A.R.T. Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 173,211 shares — an estimated $624K sold.

A.R.T. Advisors first reported a position in ACHN in Q2 2013 and held it in 18 quarters. The position peaked at $6.88M in Q3 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • A.R.T. Advisors reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 173,211 Achillion Pharmaceuticals shares in Q4 2019, an estimated $624K.
  • A.R.T. Advisors first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • A.R.T. Advisors's Achillion Pharmaceuticals position peaked at $6.88M in Q3 2014.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.